CBD is currently FDA-approved for the treatment of childhood seizure disorders Dravet and Lennox-Gastaut syndrome. Two randomised controlled trials (RCTs) have shown that, when CBD is added to existing anti-epilepsy medication in patients with these conditions, seizure frequency decreases researchers are still uncertain as to how CBD stabilizes the brain but suspect it’s the action of CBD on the neurotransmitter systems that excite and relax neuronal connections. We know of some cases that CBD is a miracle drug, stabilizing brain functions. Pre-clinical studies of CBD have shown anti-inflammatory benefits. Other studies have demonstrated CBD’s anti-anxiety effects. In this study by decreasing cerebral blood flow to anxiety processing areas of the brain and a decrease in patient-reported anxiety when compared to placebo. Even though CBD is known to reduce inflammation and symptoms associated with anxiety, there is still a lack of evidence of its therapeutic potential in a clinical setting. A recent observational study in the British Journal of General Practice set out to measure 400 patients at baseline using the Euro-Qol Research survey. These surveys determine if a new treatment really works and for what condition. Researchers in this study wanted to review the self-reported quality of life, such as a decrease in mood and pain levels. In this study, patients were prescribed CBD oil containing 100 mg administer orally via a dropper. Before taking CBD, patients were asked to take the Euro-Qol questionnaire before to measure baseline, and again after 3 weeks of using CBD. It’s important to note that the dosages taken during the study varied. Since the CBD was self-administered and taken orally in dropper, dosages ranged from 40 milligrams to 300 milligrams. This study showed CBD is well tolerated in most individuals, and can improve overall quality of life.
LEARN MORE ABOUT THC FREE CBD HERE!